Last Updated: May 11, 2026

List of Excipients in API sitagliptin phosphate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing sitagliptin phosphate

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC	Excipient
Sandoz Inc	sitagliptin phosphate	0781-5766	ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Sandoz Inc	sitagliptin phosphate	0781-5766	CELLULOSE, MICROCRYSTALLINE
Sandoz Inc	sitagliptin phosphate	0781-5766	CROSCARMELLOSE SODIUM
Sandoz Inc	sitagliptin phosphate	0781-5766	FERRIC OXIDE RED
Sandoz Inc	sitagliptin phosphate	0781-5766	FERRIC OXIDE YELLOW
Sandoz Inc	sitagliptin phosphate	0781-5766	HYDROXYPROPYL CELLULOSE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for sitagliptin phosphate

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

sitagliptin phosphate drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CELLULOSE, MICROCRYSTALLINE

sitagliptin phosphate drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

sitagliptin phosphate drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE RED

sitagliptin phosphate drug variants containing FERRIC OXIDE RED

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing FERRIC OXIDE RED

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

sitagliptin phosphate drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL CELLULOSE

sitagliptin phosphate drug variants containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

sitagliptin phosphate drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

sitagliptin phosphate drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

sitagliptin phosphate drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL

sitagliptin phosphate drug variants containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

sitagliptin phosphate drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STEARYL FUMARATE

sitagliptin phosphate drug variants containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

sitagliptin phosphate drug variants containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

sitagliptin phosphate drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	sitagliptin phosphate	0781-5766
>Company	>Ingredient	>NDC

sitagliptin phosphate drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.